drugset / Trial / NCT00935064

The Effect of Renin Inhibition on Nerve Function in Diabetes

NCT00935064

Completed 60 enrolled Christiana Care Health Services
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will assess the effect of direct renin inhibition on nerve function in persons with diabetes using a double-blind, placebo-controlled randomized trial involving two treatment arms (i.e., \[1\] 30 participants enrolled and randomized to 300 mg of Aliskiren; \[2\] 30 participants enrolled and randomized to placebo).

Timeline

Start
2009-06
Primary completion
2011-10
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aliskiren Small molecule 300 mg

Indications